The influence of rheumatoid arthritis disease characteristics on heart failure.

scientific article published on 15 May 2011

The influence of rheumatoid arthritis disease characteristics on heart failure. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3899/JRHEUM.100979
P932PMC publication ID3337549
P698PubMed publication ID21572155
P5875ResearchGate publication ID51126671

P50authorJohn M. DavisQ57081275
Cynthia S CrowsonQ87215892
Véronique L. RogerQ110955107
P2093author name stringTerry M Therneau
Sherine E Gabriel
Hilal Maradit-Kremers
Elena Myasoedova
Paulo J Nicola
P2860cites workSeventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureQ22306384
Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 yearsQ24674079
Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesisQ24812557
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisQ27860872
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportQ27861020
Diagnosis and classification of diabetes mellitusQ28299875
Report of the expert committee on the diagnosis and classification of diabetes mellitusQ34167177
Rochester Epidemiology Project: a unique resource for research in the rheumatic diseasesQ34359522
History of the Rochester Epidemiology ProjectQ34374377
The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis RegisterQ34395284
Mechanisms and models in heart failure: the biomechanical model and beyondQ34422770
Diastolic function abnormalities in rheumatoid arthritis. Evaluation By echo Doppler transmitral flow and pulmonary venous flow: relation with duration of diseaseQ35549143
Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritisQ35638288
Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritisQ35638369
Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapyQ35676074
Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health StudyQ35941063
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA studyQ36757060
Role of inflammation in the progression of heart failureQ36806972
The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population.Q37074034
Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood instituteQ37417065
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature reviewQ37640953
The epidemiology of heart failure: the Framingham StudyQ38512101
Classification of heart failure in population based research: an assessment of six heart failure scoresQ43814913
Alcohol consumption and risk for congestive heart failure in the Framingham Heart StudyQ43876632
Natural history of asymptomatic left ventricular systolic dysfunction in the communityQ43884752
Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritisQ45129989
How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?Q46732422
Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis.Q51773790
The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 yearsQ57540261
International diagnostic criteria for acute myocardial infarction and acute strokeQ71379325
Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adultsQ77367158
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factorsQ77406810
The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism AssociationQ77701974
Extra-articular rheumatoid arthritis: prevalence and mortalityQ78169221
Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort studyQ79850163
Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based studyQ80401292
Diastolic function abnormalities in rheumatoid arthritis: relation with duration of diseaseQ80407291
Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?Q80800883
The increased risk of ventricular diastolic dysfunction and congestive heart failure in patients with rheumatoid arthritis is independent of the duration of the diseaseQ81285682
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectheart failureQ181754
rheumatoid arthritisQ187255
P304page(s)1601-1606
P577publication date2011-05-15
P1433published inThe Journal of RheumatologyQ7743623
P1476titleThe influence of rheumatoid arthritis disease characteristics on heart failure
P478volume38

Reverse relations

cites work (P2860)
Q30940911A novel measure of socioeconomic status using individual housing data to assess the association of SES with rheumatoid arthritis and its mortality: a population-based case-control study.
Q52587395Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity.
Q87035377Arterial stiffness is associated with left ventricular dysfunction in patients with rheumatoid arthritis
Q38876331Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment.
Q33582869Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions.
Q26823443Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure
Q38757421Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
Q34092449Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Q93148453Early short-term ivabradine treatment in new-onset acute systolic heart failure and sinus tachycardia patients with inflammatory rheumatic disease
Q35210847Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis
Q57308303Epidemiology of heart failure with preserved ejection fraction
Q38098647Examining the risk of cardiovascular disease in patients with psoriasis: a critical review.
Q40379963Fragility Fractures Are Associated with an Increased Risk for Cardiovascular Events in Women and Men with Rheumatoid Arthritis: A Population-based Study
Q51835838Immune-Mediated Heart Disease.
Q37209902Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study
Q33595578Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study
Q52312175Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.
Q41150203Increased incidence of atrial fibrillation in patients with rheumatoid arthritis.
Q38554197Lipid and Metabolic Changes in Rheumatoid Arthritis.
Q34157718Longterm blood pressure variability in patients with rheumatoid arthritis and its effect on cardiovascular events and all-cause mortality in RA: a population-based comparative cohort study
Q33695937Myocardial Perfusion in Rheumatoid Arthritis Patients: Associations with Traditional Risk Factors and Novel Biomarkers
Q38098935Novel risk factors for cardiovascular disease in rheumatoid arthritis
Q35994802Preventing Heart Failure in Inflammatory and Immune Disorders
Q47095887Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study
Q38608511Progression rate of severity of aortic stenosis in patients with rheumatoid arthritis
Q28709376Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis
Q24630655Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity
Q34810005Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study
Q38648390Risk of Obstructive Sleep Apnea and Its Association with Cardiovascular and Noncardiac Vascular Risk in Patients with Rheumatoid Arthritis: A Population-based Study
Q92771595Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment
Q40065441Sex and Cardiovascular Involvement in Inflammatory Joint Diseases
Q36240514The Detection of Rheumatic Disease through Hospital Diagnoses with Examples of Rheumatoid Arthritis and Giant Cell Arteritis: What Are We Missing?
Q38091933The role of B-cells in heart failure
Q35904678The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease
Q85589116[Risk of atherosclerosis mediated by inflammation in rheumatoid arthritis]

Search more.